NeuroNEXT is a new NINDS-sponsored consortium of 25 neuroscience centers across the US that will participate in rapid development and implementation of clinical trials for adult and pediatric neurological disorders. NeuroNEXT is actively seeking industry partnerships to broaden the portfolio of novel treatments available to the consortium. An informational event will be held on March 28 at Swedish Neuroscience Institute for members of the local biotech community interested in learning more. For details, click here.